The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Citalopram Market Research Report 2025
Synopsis
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
The global Citalopram market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Citalopram is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Citalopram is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Citalopram in Depression is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Citalopram include H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals and Jubilant Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Citalopram, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Citalopram.
Report Scope
The Citalopram market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Citalopram market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Citalopram companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
H.Lundbeck A/S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Limited
Prinston Pharmaceutical
STI Pharma
TEVA Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical
Jiangsu Enhua Pharmaceutical
Southwest Pharmaceutical
Segment by Type
Solution
Tablets
Other
Segment by Application
Depression
Generalized Anxiety
Obsessive Compulsive Disorder
Somatoform Disorder
Schizophrenia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Citalopram companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
The global Citalopram market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Citalopram is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Citalopram is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Citalopram in Depression is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Citalopram include H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals and Jubilant Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Citalopram, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Citalopram.
Report Scope
The Citalopram market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Citalopram market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Citalopram companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
H.Lundbeck A/S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Limited
Prinston Pharmaceutical
STI Pharma
TEVA Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical
Jiangsu Enhua Pharmaceutical
Southwest Pharmaceutical
Segment by Type
Solution
Tablets
Other
Segment by Application
Depression
Generalized Anxiety
Obsessive Compulsive Disorder
Somatoform Disorder
Schizophrenia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Citalopram companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Citalopram Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solution
1.2.3 Tablets
1.2.4 Other
1.3 Market by Application
1.3.1 Global Citalopram Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Depression
1.3.3 Generalized Anxiety
1.3.4 Obsessive Compulsive Disorder
1.3.5 Somatoform Disorder
1.3.6 Schizophrenia
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Citalopram Market Perspective (2019-2030)
2.2 Citalopram Growth Trends by Region
2.2.1 Global Citalopram Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Citalopram Historic Market Size by Region (2019-2024)
2.2.3 Citalopram Forecasted Market Size by Region (2025-2030)
2.3 Citalopram Market Dynamics
2.3.1 Citalopram Industry Trends
2.3.2 Citalopram Market Drivers
2.3.3 Citalopram Market Challenges
2.3.4 Citalopram Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Citalopram Players by Revenue
3.1.1 Global Top Citalopram Players by Revenue (2019-2024)
3.1.2 Global Citalopram Revenue Market Share by Players (2019-2024)
3.2 Global Citalopram Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Citalopram Revenue
3.4 Global Citalopram Market Concentration Ratio
3.4.1 Global Citalopram Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Citalopram Revenue in 2023
3.5 Citalopram Key Players Head office and Area Served
3.6 Key Players Citalopram Product Solution and Service
3.7 Date of Enter into Citalopram Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Citalopram Breakdown Data by Type
4.1 Global Citalopram Historic Market Size by Type (2019-2024)
4.2 Global Citalopram Forecasted Market Size by Type (2025-2030)
5 Citalopram Breakdown Data by Application
5.1 Global Citalopram Historic Market Size by Application (2019-2024)
5.2 Global Citalopram Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Citalopram Market Size (2019-2030)
6.2 North America Citalopram Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Citalopram Market Size by Country (2019-2024)
6.4 North America Citalopram Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Citalopram Market Size (2019-2030)
7.2 Europe Citalopram Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Citalopram Market Size by Country (2019-2024)
7.4 Europe Citalopram Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Citalopram Market Size (2019-2030)
8.2 Asia-Pacific Citalopram Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Citalopram Market Size by Region (2019-2024)
8.4 Asia-Pacific Citalopram Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Citalopram Market Size (2019-2030)
9.2 Latin America Citalopram Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Citalopram Market Size by Country (2019-2024)
9.4 Latin America Citalopram Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Citalopram Market Size (2019-2030)
10.2 Middle East & Africa Citalopram Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Citalopram Market Size by Country (2019-2024)
10.4 Middle East & Africa Citalopram Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Detail
11.1.2 H.Lundbeck A/S Business Overview
11.1.3 H.Lundbeck A/S Citalopram Introduction
11.1.4 H.Lundbeck A/S Revenue in Citalopram Business (2019-2024)
11.1.5 H.Lundbeck A/S Recent Development
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Detail
11.2.2 Amneal Pharmaceuticals Business Overview
11.2.3 Amneal Pharmaceuticals Citalopram Introduction
11.2.4 Amneal Pharmaceuticals Revenue in Citalopram Business (2019-2024)
11.2.5 Amneal Pharmaceuticals Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Detail
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma Citalopram Introduction
11.3.4 Aurobindo Pharma Revenue in Citalopram Business (2019-2024)
11.3.5 Aurobindo Pharma Recent Development
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Detail
11.4.2 Hetero Drugs Business Overview
11.4.3 Hetero Drugs Citalopram Introduction
11.4.4 Hetero Drugs Revenue in Citalopram Business (2019-2024)
11.4.5 Hetero Drugs Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Detail
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Citalopram Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Citalopram Business (2019-2024)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Detail
11.6.2 Silarx Pharmacueticals Business Overview
11.6.3 Silarx Pharmacueticals Citalopram Introduction
11.6.4 Silarx Pharmacueticals Revenue in Citalopram Business (2019-2024)
11.6.5 Silarx Pharmacueticals Recent Development
11.7 Apotex
11.7.1 Apotex Company Detail
11.7.2 Apotex Business Overview
11.7.3 Apotex Citalopram Introduction
11.7.4 Apotex Revenue in Citalopram Business (2019-2024)
11.7.5 Apotex Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Detail
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals Citalopram Introduction
11.8.4 Hikma Pharmaceuticals Revenue in Citalopram Business (2019-2024)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Detail
11.9.2 Jubilant Pharma Business Overview
11.9.3 Jubilant Pharma Citalopram Introduction
11.9.4 Jubilant Pharma Revenue in Citalopram Business (2019-2024)
11.9.5 Jubilant Pharma Recent Development
11.10 Lupin Limited
11.10.1 Lupin Limited Company Detail
11.10.2 Lupin Limited Business Overview
11.10.3 Lupin Limited Citalopram Introduction
11.10.4 Lupin Limited Revenue in Citalopram Business (2019-2024)
11.10.5 Lupin Limited Recent Development
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Detail
11.11.2 Prinston Pharmaceutical Business Overview
11.11.3 Prinston Pharmaceutical Citalopram Introduction
11.11.4 Prinston Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.11.5 Prinston Pharmaceutical Recent Development
11.12 STI Pharma
11.12.1 STI Pharma Company Detail
11.12.2 STI Pharma Business Overview
11.12.3 STI Pharma Citalopram Introduction
11.12.4 STI Pharma Revenue in Citalopram Business (2019-2024)
11.12.5 STI Pharma Recent Development
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Detail
11.13.2 TEVA Pharmaceutical Business Overview
11.13.3 TEVA Pharmaceutical Citalopram Introduction
11.13.4 TEVA Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.13.5 TEVA Pharmaceutical Recent Development
11.14 Hexal
11.14.1 Hexal Company Detail
11.14.2 Hexal Business Overview
11.14.3 Hexal Citalopram Introduction
11.14.4 Hexal Revenue in Citalopram Business (2019-2024)
11.14.5 Hexal Recent Development
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Detail
11.15.2 Shanghai Great Wall Pharmaceutical Business Overview
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Introduction
11.15.4 Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.15.5 Shanghai Great Wall Pharmaceutical Recent Development
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Detail
11.16.2 Wanquan Wante Pharmaceutical Business Overview
11.16.3 Wanquan Wante Pharmaceutical Citalopram Introduction
11.16.4 Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.16.5 Wanquan Wante Pharmaceutical Recent Development
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Detail
11.17.2 Northeast Pharmaceutical Group Business Overview
11.17.3 Northeast Pharmaceutical Group Citalopram Introduction
11.17.4 Northeast Pharmaceutical Group Revenue in Citalopram Business (2019-2024)
11.17.5 Northeast Pharmaceutical Group Recent Development
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Detail
11.18.2 Sichuan Kelun Pharmaceutical Business Overview
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Introduction
11.18.4 Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.18.5 Sichuan Kelun Pharmaceutical Recent Development
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Detail
11.19.2 Kunming Jida Pharmaceutical Business Overview
11.19.3 Kunming Jida Pharmaceutical Citalopram Introduction
11.19.4 Kunming Jida Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.19.5 Kunming Jida Pharmaceutical Recent Development
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Detail
11.20.2 Jiangsu Enhua Pharmaceutical Business Overview
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Introduction
11.20.4 Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.20.5 Jiangsu Enhua Pharmaceutical Recent Development
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Detail
11.21.2 Southwest Pharmaceutical Business Overview
11.21.3 Southwest Pharmaceutical Citalopram Introduction
11.21.4 Southwest Pharmaceutical Revenue in Citalopram Business (2019-2024)
11.21.5 Southwest Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Citalopram Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Solution
Table 3. Key Players of Tablets
Table 4. Key Players of Other
Table 5. Global Citalopram Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Citalopram Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Citalopram Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Citalopram Market Share by Region (2019-2024)
Table 9. Global Citalopram Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Citalopram Market Share by Region (2025-2030)
Table 11. Citalopram Market Trends
Table 12. Citalopram Market Drivers
Table 13. Citalopram Market Challenges
Table 14. Citalopram Market Restraints
Table 15. Global Citalopram Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Citalopram Market Share by Players (2019-2024)
Table 17. Global Top Citalopram Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Citalopram as of 2023)
Table 18. Ranking of Global Top Citalopram Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Citalopram Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Citalopram Product Solution and Service
Table 22. Date of Enter into Citalopram Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Citalopram Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Citalopram Revenue Market Share by Type (2019-2024)
Table 26. Global Citalopram Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Citalopram Revenue Market Share by Type (2025-2030)
Table 28. Global Citalopram Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Citalopram Revenue Market Share by Application (2019-2024)
Table 30. Global Citalopram Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Citalopram Revenue Market Share by Application (2025-2030)
Table 32. North America Citalopram Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Citalopram Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Citalopram Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Citalopram Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Citalopram Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Citalopram Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Citalopram Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Citalopram Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Citalopram Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Citalopram Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Citalopram Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Citalopram Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Citalopram Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Citalopram Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Citalopram Market Size by Country (2025-2030) & (US$ Million)
Table 47. H.Lundbeck A/S Company Detail
Table 48. H.Lundbeck A/S Business Overview
Table 49. H.Lundbeck A/S Citalopram Product
Table 50. H.Lundbeck A/S Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 51. H.Lundbeck A/S Recent Development
Table 52. Amneal Pharmaceuticals Company Detail
Table 53. Amneal Pharmaceuticals Business Overview
Table 54. Amneal Pharmaceuticals Citalopram Product
Table 55. Amneal Pharmaceuticals Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 56. Amneal Pharmaceuticals Recent Development
Table 57. Aurobindo Pharma Company Detail
Table 58. Aurobindo Pharma Business Overview
Table 59. Aurobindo Pharma Citalopram Product
Table 60. Aurobindo Pharma Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 61. Aurobindo Pharma Recent Development
Table 62. Hetero Drugs Company Detail
Table 63. Hetero Drugs Business Overview
Table 64. Hetero Drugs Citalopram Product
Table 65. Hetero Drugs Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 66. Hetero Drugs Recent Development
Table 67. Macleods Pharmaceuticals Company Detail
Table 68. Macleods Pharmaceuticals Business Overview
Table 69. Macleods Pharmaceuticals Citalopram Product
Table 70. Macleods Pharmaceuticals Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 71. Macleods Pharmaceuticals Recent Development
Table 72. Silarx Pharmacueticals Company Detail
Table 73. Silarx Pharmacueticals Business Overview
Table 74. Silarx Pharmacueticals Citalopram Product
Table 75. Silarx Pharmacueticals Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 76. Silarx Pharmacueticals Recent Development
Table 77. Apotex Company Detail
Table 78. Apotex Business Overview
Table 79. Apotex Citalopram Product
Table 80. Apotex Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 81. Apotex Recent Development
Table 82. Hikma Pharmaceuticals Company Detail
Table 83. Hikma Pharmaceuticals Business Overview
Table 84. Hikma Pharmaceuticals Citalopram Product
Table 85. Hikma Pharmaceuticals Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 86. Hikma Pharmaceuticals Recent Development
Table 87. Jubilant Pharma Company Detail
Table 88. Jubilant Pharma Business Overview
Table 89. Jubilant Pharma Citalopram Product
Table 90. Jubilant Pharma Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 91. Jubilant Pharma Recent Development
Table 92. Lupin Limited Company Detail
Table 93. Lupin Limited Business Overview
Table 94. Lupin Limited Citalopram Product
Table 95. Lupin Limited Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 96. Lupin Limited Recent Development
Table 97. Prinston Pharmaceutical Company Detail
Table 98. Prinston Pharmaceutical Business Overview
Table 99. Prinston Pharmaceutical Citalopram Product
Table 100. Prinston Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 101. Prinston Pharmaceutical Recent Development
Table 102. STI Pharma Company Detail
Table 103. STI Pharma Business Overview
Table 104. STI Pharma Citalopram Product
Table 105. STI Pharma Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 106. STI Pharma Recent Development
Table 107. TEVA Pharmaceutical Company Detail
Table 108. TEVA Pharmaceutical Business Overview
Table 109. TEVA Pharmaceutical Citalopram Product
Table 110. TEVA Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 111. TEVA Pharmaceutical Recent Development
Table 112. Hexal Company Detail
Table 113. Hexal Business Overview
Table 114. Hexal Citalopram Product
Table 115. Hexal Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 116. Hexal Recent Development
Table 117. Shanghai Great Wall Pharmaceutical Company Detail
Table 118. Shanghai Great Wall Pharmaceutical Business Overview
Table 119. Shanghai Great Wall Pharmaceutical Citalopram Product
Table 120. Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 121. Shanghai Great Wall Pharmaceutical Recent Development
Table 122. Wanquan Wante Pharmaceutical Company Detail
Table 123. Wanquan Wante Pharmaceutical Business Overview
Table 124. Wanquan Wante Pharmaceutical Citalopram Product
Table 125. Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 126. Wanquan Wante Pharmaceutical Recent Development
Table 127. Northeast Pharmaceutical Group Company Detail
Table 128. Northeast Pharmaceutical Group Business Overview
Table 129. Northeast Pharmaceutical Group Citalopram Product
Table 130. Northeast Pharmaceutical Group Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 131. Northeast Pharmaceutical Group Recent Development
Table 132. Sichuan Kelun Pharmaceutical Company Detail
Table 133. Sichuan Kelun Pharmaceutical Business Overview
Table 134. Sichuan Kelun Pharmaceutical Citalopram Product
Table 135. Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 136. Sichuan Kelun Pharmaceutical Recent Development
Table 137. Kunming Jida Pharmaceutical Company Detail
Table 138. Kunming Jida Pharmaceutical Business Overview
Table 139. Kunming Jida Pharmaceutical Citalopram Product
Table 140. Kunming Jida Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 141. Kunming Jida Pharmaceutical Recent Development
Table 142. Jiangsu Enhua Pharmaceutical Company Detail
Table 143. Jiangsu Enhua Pharmaceutical Business Overview
Table 144. Jiangsu Enhua Pharmaceutical Citalopram Product
Table 145. Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 146. Jiangsu Enhua Pharmaceutical Recent Development
Table 147. Southwest Pharmaceutical Company Detail
Table 148. Southwest Pharmaceutical Business Overview
Table 149. Southwest Pharmaceutical Citalopram Product
Table 150. Southwest Pharmaceutical Revenue in Citalopram Business (2019-2024) & (US$ Million)
Table 151. Southwest Pharmaceutical Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Citalopram Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Citalopram Market Share by Type: 2023 VS 2030
Figure 3. Solution Features
Figure 4. Tablets Features
Figure 5. Other Features
Figure 6. Global Citalopram Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Citalopram Market Share by Application: 2023 VS 2030
Figure 8. Depression Case Studies
Figure 9. Generalized Anxiety Case Studies
Figure 10. Obsessive Compulsive Disorder Case Studies
Figure 11. Somatoform Disorder Case Studies
Figure 12. Schizophrenia Case Studies
Figure 13. Other Case Studies
Figure 14. Citalopram Report Years Considered
Figure 15. Global Citalopram Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Citalopram Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Citalopram Market Share by Region: 2023 VS 2030
Figure 18. Global Citalopram Market Share by Players in 2023
Figure 19. Global Top Citalopram Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Citalopram as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Citalopram Revenue in 2023
Figure 21. North America Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Citalopram Market Share by Country (2019-2030)
Figure 23. United States Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Citalopram Market Share by Country (2019-2030)
Figure 27. Germany Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Citalopram Market Share by Region (2019-2030)
Figure 35. China Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Citalopram Market Share by Country (2019-2030)
Figure 43. Mexico Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Citalopram Market Share by Country (2019-2030)
Figure 47. Turkey Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Citalopram Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. H.Lundbeck A/S Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 50. Amneal Pharmaceuticals Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 51. Aurobindo Pharma Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 52. Hetero Drugs Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 53. Macleods Pharmaceuticals Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 54. Silarx Pharmacueticals Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 55. Apotex Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 56. Hikma Pharmaceuticals Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 57. Jubilant Pharma Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 58. Lupin Limited Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 59. Prinston Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 60. STI Pharma Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 61. TEVA Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 62. Hexal Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 63. Shanghai Great Wall Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 64. Wanquan Wante Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 65. Northeast Pharmaceutical Group Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 66. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 67. Kunming Jida Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 68. Jiangsu Enhua Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 69. Southwest Pharmaceutical Revenue Growth Rate in Citalopram Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
